E. Frigerio
Publications by Year
Research Areas
Antibiotics Pharmacokinetics and Efficacy, Analytical Chemistry and Chromatography, Cancer therapeutics and mechanisms, Pharmacogenetics and Drug Metabolism, Computational Drug Discovery Methods
Most-Cited Works
- Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.(1999)
- → Polymer-bound camptothecin: initial biodistribution and antitumour activity studies(2000)154 cited
- → Population pharmacokinetics in phase I drug development: a phase I study of PK1 in patients with solid tumours(1999)81 cited
- → CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study(2013)76 cited
- → Quantitation of SU11248, an oral multi-target tyrosine kinase inhibitor, and its metabolite in monkey tissues by liquid chromatograph with tandem mass spectrometry following semi-automated liquid–liquid extraction(2003)60 cited
- → Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein binding(1995)59 cited
- → Stereoselective and species‐dependent kinetics of reboxetine in mouse and rat(1995)51 cited
- → Bioanalytical method validation: a risk-based approach?(2004)45 cited
- → LC–MS–MS determination of exemestane in human plasma with heated nebulizer interface following solid-phase extraction in the 96 well plate format(2000)40 cited
- → Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects(2012)37 cited